BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2320181)

  • 21. Elevated activities and properties of arylsulfatases A and B and B-variant in human lung tumors.
    Gasa S; Makita A; Kameya T; Kodama T; Araki E; Yoneyama T; Hirama M; Hashimoto M
    Cancer Res; 1980 Oct; 40(10):3804-9. PubMed ID: 7438063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of cathepsin B correlates with angiogenesis in colon adenocarcinoma.
    Kruszewski WJ; Rzepko R; Wojtacki J; Skokowski J; Kopacz A; Jaśkiewicz K; Drucis K
    Neoplasma; 2004; 51(1):38-43. PubMed ID: 15004658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cathepsin B in human breast tumor tissue and cancer cells.
    Krepela E; Vicar J; Cernoch M
    Neoplasma; 1989; 36(1):41-52. PubMed ID: 2704424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cathepsin B expression and its correlation with tumor-associated laminin and tumor progression in gastric cancer.
    Khan A; Krishna M; Baker SP; Malhothra R; Banner BF
    Arch Pathol Lab Med; 1998 Feb; 122(2):172-7. PubMed ID: 9499362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical indicators of malignancy of lung cancer].
    Abe S; Sukoh N; Ogura S; Isobe H
    Hokkaido Igaku Zasshi; 1994 May; 69(3):391-5. PubMed ID: 7927167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
    Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
    Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue MMP-2 and MMP-9 [corrected] are better prognostic factors than serum MMP-2/TIMP-2--complex or TIMP-1 [corrected] in stage [corrected] I-III lung carcinoma.
    Hoikkala S; Pääkkö P; Soini Y; Mäkitaro R; Kinnula V; Turpeenniemi-Hujanen T
    Cancer Lett; 2006 May; 236(1):125-32. PubMed ID: 15982804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lysosomal dipeptidyl-peptidases I and II in human squamous cell lung carcinoma and lung parenchyma.
    Krepela E; Procházka J; Mynaríková H; Kárová B; Cermák J; Roubková H
    Neoplasma; 1996; 43(3):171-8. PubMed ID: 8841504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinoma.
    Talieri M; Papadopoulou S; Scorilas A; Xynopoulos D; Arnogianaki N; Plataniotis G; Yotis J; Agnanti N
    Cancer Lett; 2004 Mar; 205(1):97-106. PubMed ID: 15036666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Total and lipid-bound plasma sialic acid as diagnostic markers in colorectal cancer patients: correlation with cathepsin B expression in progression to Dukes stage.
    Sebzda T; Saleh Y; Gburek J; Warwas M; Andrzejak R; Siewinski M; Rudnicki J
    J Exp Ther Oncol; 2006; 5(3):223-9. PubMed ID: 16528972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aryl hydrocarbon hydroxylase activity in human lung tissue: in relation to cigarette smoking and lung cancer.
    Yoshikawa M; Arashidani K; Kawamoto T; Kodama Y
    Environ Res; 1994 Apr; 65(1):1-11. PubMed ID: 8162876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of a tumor-associated protein kinase (p40TAK) and casein kinase 2 in human squamous cell carcinomas and adenocarcinomas of the lung.
    Daya-Makin M; Sanghera JS; Mogentale TL; Lipp M; Parchomchuk J; Hogg JC; Pelech SL
    Cancer Res; 1994 Apr; 54(8):2262-8. PubMed ID: 7513612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dipeptidyl peptidase IV, prolyl endopeptidase and cathepsin B activities in primary human lung tumors and lung parenchyma.
    Sedo A; Krepela E; Kasafírek E
    J Cancer Res Clin Oncol; 1991; 117(3):249-53. PubMed ID: 1674512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cathepsin B activity and concentration of elastase and alpha-1 proteinase inhibitor complex in non-small-cell lung cancer: 2 year follow-up study].
    Passowicz-Muszyńska E; Jankowska R; Gołab K; Marciniak M; Warwas M
    Pol Merkur Lekarski; 2003 May; 14(83):417-20. PubMed ID: 12939816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship of cathepsin B and stefin A mRNA localization identifies a potentially aggressive variant of human prostate cancer within a Gleason histologic score.
    Sinha AA; Quast BJ; Korkowski JC; Wilson MJ; Reddy PK; Ewing SL; Sloane BF; Gleason DF
    Anticancer Res; 1999; 19(4B):2821-9. PubMed ID: 10652560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High expression of cathepsin B in transitional bladder carcinoma correlates with tumor invasion.
    Eiján AM; Sandes EO; Riveros MD; Thompson S; Pasik L; Mallagrino H; Celeste F; Casabé AR
    Cancer; 2003 Jul; 98(2):262-8. PubMed ID: 12872343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cathepsin B in angiogenesis of human prostate: an immunohistochemical and immunoelectron microscopic analysis.
    Sinha AA; Gleason DF; Staley NA; Wilson MJ; Sameni M; Sloane BF
    Anat Rec; 1995 Mar; 241(3):353-62. PubMed ID: 7538734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cathepsin B in cells of two rat sarcomas with different rates of spontaneous metastasis.
    Krepela E; Veselý P; Chaloupková A; Zicha D; Urbanec P; Rasnick D; Vicar J
    Neoplasma; 1989; 36(5):529-40. PubMed ID: 2812149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A possible application of cathepsin B activity determination for estimating the spread of the cervix uteri carcinoma.
    Makarewicz R; Drewa G
    Acta Biochim Pol; 1996; 43(3):521-4. PubMed ID: 8922036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cathepsin B in predicting the extent of the cervix carcinoma.
    Makarewicz R; Drewa G; Szymanski W; Skonieczna-Makarewicz I
    Neoplasma; 1995; 42(1):21-4. PubMed ID: 7617069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.